Treating Clostridioides difficile infection is complicated in patients coinfected with COVID-19. However, a new study suggests a significant benefit of fecal microbiota transplant (FMT) in these coinfected patients.
Samantha DiGrande
Advertisement
Articles by Samantha DiGrande
In a new study, Michigan State University investigators identified an immune receptor, SLAMF7, that had the ability to decrease immune response when activated on monocytes.
Advertisement
Latest Updated Articles
Damage to Immune Receptor Could Spur Comorbidities in Patients With HIVPublished: January 18th 2019 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Top Infectious Disease News Stories Week of November 29 - December 5
2
Early 2025 Influenza Vaccination Trends Following Prior Season and H3N2 Start
3
Population Study Confirms Rare Risk of Acute Respiratory Failure with TMP-SMX
4
Delaying the Birth Dose of Hepatitis B Vaccine Could Lead to More Infections, Greater Costs
5
